Chemical substances in Batch 5 of the Challenge
On this page
- Summary of Batch 5 substances and publications
- Timelines
- Substance Groupings Initiative
- Risk management action milestones
- Adding substances to Schedule 1
- Significant New Activity (SNAc) provisions
- Applying SNAc provisions
- Varying the requirements under the SNAc provisions
- Rescinding requirements under the SNAc provisions
- Final screening assessments and risk management approaches
- Draft screening assessments and risk management scopes
- Information gathering
Summary of Batch 5 substances and publications
| CAS RN | Chemical substance | Final order and RIAS | Public comments on the proposed risk management approach | Final screening assessment | Proposed risk management approach | Public comments on the draft screening assessment and risk management scope |
|---|---|---|---|---|---|---|
| 79-06-1 | Acrylamide | HTML | HTML | HTML | HTML | HTML |
| 115-96-8 | TCEP | HTML | HTML | HTML | HTML | HTML |
| CAS RN | Chemical substance | Final screening assessment | Public comments |
|---|---|---|---|
| 5261-31-4 | Disperse Orange 30 | HTML | HTML |
| 6232-56-0 | Disperse Orange 5 | HTML | None |
| 12239-34-8 | Disperse Blue 79 | HTML | HTML |
| 16421-40-2 | ANAM | HTML | HTML |
| 16421-41-3 | AADM | HTML | HTML |
| 17464-91-4 | Disperse Brown 1:1 | HTML | HTML |
| 23355-64-8 | Disperse Brown 1 | HTML | HTML |
| 26850-12-4 | Disperse Red 167 | HTML | HTML |
| 29765-00-2 | BANAP | HTML | HTML |
| 52697-38-8 | BDAP | HTML | HTML |
| 55281-26-0 | Disperse Orange 61 | HTML | HTML |
| 55619-18-6 | EDD | HTML | HTML |
| 72927-94-7 | DNAN | HTML | HTML |
| 75-12-7 | Formamide | HTML | HTML |
| 79-07-2 | 2-Chloroacetamide | HTML | HTML |
| 126-73-8 | TBP | HTML | None |
| 127-19-5 | DMAc | HTML | None |
Timelines
| Date | Substances affected | Activity |
|---|---|---|
| March 25, 2026 | CAS RN 79-07-2 | Publication in the Canada Gazette, Part II, of an order amending the Domestic Substances List (DSL) to vary the requirements under the SNAc provisions of CEPA. |
| February 5, 2022 | CAS RN 79-07-2 | Publication in the Canada Gazette, Part I, of a notice of intent to amend the DSL to vary the requirements under the SNAc provisions of CEPA and start of 60-day public comment period. |
| August 28, 2019 | CAS RN 126-73-8 | Publication of a summary of risk assessments and management of flame-retardant substances under CEPA. |
| July 12, 2017 | CAS RN 6232-56-0 | Publication in the Canada Gazette, Part II, of an order rescinding the requirements under the SNAc provisions of CEPA. |
| January 14, 2017 | CAS RN 115-96-8 | Publication in the Canada Gazette, Part I, of a notice of intent to amend the DSL to vary the requirements under the SNAc provisions of CEPA and start of 60-day public comment period. |
| January 30, 2013 | CAS RN 115-96-8 | Publication in Canada Gazette, Part II, of an order amending the DSL to apply the SNAc provisions of CEPA. |
| July 30, 2011 | CAS RN 115-96-8 | Publication in Canada Gazette, Part I, of a notice of intent to amend the DSL to apply the SNAc provisions of CEPA and start of 60-day public comment period. |
| March 2, 2011 | CAS RNs 79-06-1 and 115-96-8 | Publication in Canada Gazette, Part II, of a final order adding two substances to Schedule 1 to CEPA. |
| November 10, 2010 | CAS RN 79-07-2 | Publication in Canada Gazette, Part II, of an order amending the DSL to apply the SNAc provisions of CEPA. |
| October 3, 2009 | CAS RNs 79-06-1 and 115-96-8 | Publication in Canada Gazette, Part I, of a proposed order adding substances to Schedule 1 to CEPA and start of 60-day public comment period. |
| August 22, 2009 | All Batch 5 substances | Publication in Canada Gazette, Part I, of the final assessment decision under subsection 77(6), release of proposed risk management approaches, and start of 60-day public comment period on the proposed risk management approaches. |
| February 21, 2009 | All Batch 5 substances | Publication in Canada Gazette, Part I, and start of 60-day public comment period on (a) the draft screening assessment, (b) the proposal to pursue 1 of the measures as specified under subsection 77(2) and (c) the risk management scopes. |
| February 21, 2009 | CAS RN 6232-56-0 | Publication in Canada Gazette, Part I, of a notice of intent to amend the DSL to apply the SNAc provisions of CEPA and start of 60-day public comment period. |
| August 15, 2008 | All Batch 5 substances | Deadline for submission of additional information by interested stakeholders, including on the extent and nature of the management/stewardship of Batch 5 substances. |
| June 17, 2008 | All Batch 5 substances | Deadline for submission of information under the section 71 notice on Batch 5 substances (if no extension granted). |
| February 16, 2008 | All Batch 5 substances | Release of Batch 5 of the Challenge and the accompanying technical documents. |
Substance Groupings Initiative
The following substances in this batch have been included in the Aromatic Azo and Benzidine-based Substance Grouping under Substance Groupings Initiative as part of the second phase of the Chemicals Management Plan. As outlined in the notice of intent for the Aromatic Azo and Benzidine-based Substance Grouping, it was recognized that assessments and conclusions pertaining to some of the substances in the grouping may be subsequently updated as part of the subgroup assessment. The latest updates on these substances are found on the respective Substance Groupings Initiative pages.
| CAS RN | Chemical substances | Substance Groupings Initiative |
|---|---|---|
| 5261-31-4 | Disperse Orange 30 | Azo Disperse Dyes |
| 6232-56-0 | Disperse Orange 5 | |
| 12239-34-8 | Disperse Blue 79 | |
| 17464-91-4 | Disperse Brown 1:1 | |
| 23355-64-8 | Disperse Brown 1 | |
| 26850-12-4 | Disperse Red 167 | |
| 55281-26-0 | Disperse Orange 61 | |
| 16421-40-2 | Disperse Blue 130 | |
| 16421-41-3 | AADM | |
| 29765-00-2 | BANAP | |
| 52697-38-8 | Acetamide, N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5-(diethylamino)phenyl]- | |
| 55619-18-6 | EDD | |
| 72927-94-7 | Benzenamine, 4-[(2,6-dichloro-4-nitrophenyl)azo]-N-(4-nitrophenyl)- |
Risk management action milestones
The risk management action milestones table outlines the risk management actions that were proposed for each chemical substance in this batch of the Challenge that met the criteria of section 64 of CEPA. These proposed risk management actions were published in the risk management approaches for these substances. For the complete wording of these proposed actions, please refer to the risk management approaches.
Adding substances to Schedule 1
Two substances in this batch have been added to Schedule 1 to CEPA.
- Final order adding acrylamide (CAS RN 79-06-1) and TCEP (CAS RN 115-96-8): Canada Gazette, Part II: Vol. 145, No. 5 - March 2, 2011
Significant New Activity (SNAc) provisions
View the SNAc publications under CEPA. Orders are subject to potential amendments under the SNAc Review.
Applying SNAc provisions
In January 2017, an order amending the DSL to apply the SNAc provisions of CEPA to TCEP (CAS RN 115-96-8) was published:
In November 2010, an order amending the DSL to apply the SNAc provisions of CEPA to chloroacetamide (CAS RN 79-07-2) was published:
In September 2009, an order amending the DSL to apply the SNAc provisions of CEPA to Disperse Orange 5 (CAS RN 6232-56-0) was published:
For additional guidance on submitting information required as part of SNAc requirements, please see the Guidance document for the New Substances Notification Regulations (Chemicals and Polymers).
Varying the requirements under the SNAc provisions
In March 2026, an order amending the DSL to vary the requirements under the SNAc provisions of CEPA for 2-chloroacetamide (CAS RN 79-07-2) was published in the Canada Gazette, Part II: Vol. 160, No. 6 – March 25, 2026. The amendments are an outcome of the SNAc Review.
In January 2017, a notice of intent to amend the DSL to vary the requirements under the SNAc provisions of CEPA for TCEP (CAS RN 115-96-8) was published in the Canada Gazette, Part I: Vol. 151, No. 2 - January 14, 2017. The proposed amendments are an outcome of the SNAc Review. The DSL amendments do not come into force until the final order is published in the Canada Gazette, Part II. Any current requirements under the SNAc provisions remain in effect until then.
Rescinding requirements under the SNAc provisions
In July 2017, an order rescinding the requirements under the SNAc provisions of CEPA for Disperse Orange 5 (CAS RN 6232-56-0) was published in the Canada Gazette, Part II: Vol. 151, No. 14 - July 12, 2017. This substance was subject to the SNAc provisions as a result of the 2009 assessment of substances in this batch. Since then, it was included in the Certain Azo Disperse Dyes subgroup, assessed in March 2017, and concluded to not be of concern to the environment.
Final screening assessments and risk management approaches
In August 2009, the final screening assessments for this batch were released and the related notices were published in the Canada Gazette, Part I: Vol. 143, No. 34 - August 22, 2009.
The final screening assessments concluded that two substances in this batch meet 1 or more criteria in section 64 of CEPA. The Government added these substances to Schedule 1 to CEPA. Proposed risk management approaches were also released on this date for the substances in this batch which met the criteria in section 64 of CEPA.
Draft screening assessments and risk management scopes
New information was received from industry or interested stakeholders for each of the 19 substances in this batch. In February 2009, the draft screening assessments were released and the related notices were published in the Canada Gazette, Part I: Vol. 143, No. 8 - February 21, 2009. Risk management scopes were also released in conjunction with these publications.
Information gathering
2008 Mandatory survey - section 71 notice
In February 2008, a notice was issued in Canada Gazette, Part I: Vol. 142, No. 7 - February 16, 2008 under section 71 of CEPA. This notice applied to all 19 substances in this batch.